● Recruiting

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

Condition: Guillain-Barre Syndrome · Sponsor: Annexon, Inc.

PhasePhase 3

Planned participants30

Who can joinAll sexes, 12 Years to 85 Years

Healthy volunteersNo

About this study

The goal of this open label study is to measure pharmacokinetics, pharmacodynamics, early efficacy, and safety of tanruprubart in adult and pediatric participants, in the United States, Canada, and Europe.

This description comes directly from the study's public registry record.

Talk to the study team

Study Coordinator · 1-650-822-5500 · clinicaltrials@annexonbio.com

Always discuss trial participation with your own doctor first.

Locations (13)

St. Joseph's Hospital & Medical Center - Barrow Neurological Institute	Phoenix, Arizona, United States	Recruiting
HonorHealth Bob Bové Neuroscience Institute	Scottsdale, Arizona, United States	Recruiting
Profound Research LLC	Carlsbad, California, United States	Recruiting
Children's Hospital of Orange County	Orange, California, United States	Recruiting
University of California Irvine	Orange, California, United States	Recruiting
University of Colorado Hospital	Aurora, Colorado, United States	Recruiting
Mayo Clinic Florida	Jacksonville, Florida, United States	Recruiting
University of Kansas Medical Center	Kansas City, Kansas, United States	Recruiting
Ochsner LSU Health	Shreveport, Louisiana, United States	Recruiting
University Massachusetts Chan Medical School	Worcester, Massachusetts, United States	Recruiting
Henry Ford Health	Detroit, Michigan, United States	Recruiting
Mayo Rochester	Rochester, Minnesota, United States	Recruiting

+ 1 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07020819